Evidence suggests that MYOSLID plays a pivotal role in driving tumor progression by modulating EMT, a process that enhances the metastatic potential of cancer cells by enabling them to adopt mesenchymal traits, thereby promoting their migratory and invasive abilities as tabulated in Table 1. The gene discussed is MYOSLID; the disease is cancer.